コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 infants devote the majority of their time to sleeping.
2 e time with screens than any activity except sleeping.
3 ng from playing sports, to driving, and even sleeping.
4 SPW-R was more pronounced during waking than sleeping.
5 r in the brain waves that occur while we are sleeping.
6 allowing (2.1, 1.1-3.9; p=0.017), difficulty sleeping (1.9, 1.3-2.8; p=0.001), arthralgias (2.0, 1.1-
7 expected left) in a small sample (n = 12) of sleeping 2-3 year olds with autism in contrast to typica
8 Telomeres were on average 6% shorter in men sleeping 5 hours or fewer compared with those sleeping m
15 s with KCN should inquire about breathing or sleeping and, when appropriate, refer patients for evalu
16 tial (LFP) recordings on flies spontaneously sleeping, and compare their brain activity to flies indu
19 the new design, especially the second-storey sleeping area because of the privacy and security of ups
20 choretic insect that hides within its host's sleeping area manages to travel long distances is not ye
21 t time, how leaving worn clothing exposed in sleeping areas when travelling can be exploited by bed b
25 incidence of botulism in shoreline birds at Sleeping Bear Dunes National Lakeshore (SLBE) in Lake Mi
27 bling times of 5-10 years at Sturgeon Point, Sleeping Bear Dunes, and Eagle Harbor, but these concent
28 while remote areas, such as Eagle Harbor and Sleeping Bear Dunes, exhibited the lowest levels (0.050-
29 ased sequencing and bioinformatics pipeline, Sleeping Beauty (SB) capture hybridization sequencing (S
30 son mutagenesis strategy based on a two-step Sleeping Beauty (SB) forward genetic screen to identify
31 We have conducted a mutagenic screen using Sleeping Beauty (SB) in mice to identify new candidate c
34 e have advanced DNA vectors derived from the Sleeping Beauty (SB) system to avoid the expense and man
36 ectal cancer (CRC) progression, we performed Sleeping Beauty (SB) transposon mutagenesis screens in m
39 driving leukemia, we targeted cre-dependent Sleeping Beauty (SB) transposon mutagenesis to the blood
44 n efficient non-viral approach combining the Sleeping Beauty (SB) Transposon System with selective pr
48 a development and metastasis, we performed a Sleeping Beauty (SB) transposon-based forward genetic sc
49 ic drivers of MPNST development, we used the Sleeping Beauty (SB) transposon-based somatic mutagenesi
52 ying a mutant allele of Apc (Apc(Min)) using Sleeping Beauty (SB) transposon-mediated mutagenesis.
53 lls that were genetically modified using the Sleeping Beauty (SB) transposon/transposase system to ex
54 ite profiling of the piggyBac (PB), Tol2 and Sleeping Beauty (SB) transposons and the murine leukemia
55 IDO expression, through a human IDO-encoding Sleeping Beauty (SB)-based nonviral gene-integrating app
58 The germline transposition frequency for Sleeping Beauty and piggyBac was approximately 10% or ab
59 ON) and compare them with the preferences of Sleeping Beauty and piggyBac, showing that each superfam
60 were obtained by non-viral gene transfer of Sleeping Beauty DNA plasmids and selectively expanded ex
61 lated when delivered into the genome via the Sleeping Beauty DNA transposon, suggesting that the obse
62 tract cancer susceptibility gene in multiple Sleeping Beauty DNA transposon-based forward genetic scr
63 gene for colorectal cancer (CRC) in several Sleeping Beauty DNA transposon-based forward genetic scr
65 ose loss accelerates tumorigenesis following Sleeping Beauty insertional mutagenesis in a mouse model
71 ly modified T cells were generated using the Sleeping Beauty system to stably introduce the CD19-spec
73 d to ubiquitously express either piggyBac or Sleeping Beauty transposase were generated by standard z
75 retrotransposition but were inactive against Sleeping Beauty transposition and long interspersed nucl
77 5 (Stat5b-CA) with mice in which a mutagenic Sleeping Beauty transposon (T2/Onc) was mobilized only i
82 ectly tested this hypothesis by performing a Sleeping Beauty transposon mutagenesis screen in which c
86 ophic induced pluripotent stem cells using a Sleeping Beauty transposon system carrying the micro-utr
87 performed insertional mutagenesis using the Sleeping Beauty transposon system in mice carrying germl
88 an insertional mutagenesis screen using the Sleeping Beauty transposon system in mice with mammary-s
89 Recently in Nature, Sun et al. (2014) used a sleeping beauty transposon system to demonstrate that na
91 were hydrodynamically codelivered using the Sleeping Beauty transposon to initiate liver tumorigenes
92 d mobilization of a single-copy inactivating Sleeping Beauty transposon to Pten disruption within the
93 in the biliary tract was accomplished by the Sleeping Beauty transposon transfection system with tran
94 Exploiting the local hopping activity of the Sleeping Beauty transposon, the lacZ reporter gene was d
98 Using a novel tyrosinase minigene-tagged Sleeping Beauty transposon-mediated mutagenesis, which a
100 in cultured human PAX7+ satellite cells with Sleeping Beauty transposon-mediated nonviral gene transf
104 ession of hMet and mutant-beta-catenin using sleeping beauty transposon/transposase leads to hepatoce
105 essing mice and forward genetic screens with Sleeping Beauty transposons implicate additional signali
107 ion elements, which were further deployed by Sleeping Beauty transposons throughout the genome of hum
109 ome-wide analysis of 23,417 piggyBac, 30,303 Sleeping Beauty, and 27,985 TcBuster integrations in HEK
110 le with two transposon systems, PiggyBac and Sleeping Beauty, and give guidance on the use of differe
111 alterations of human ICC, we electroporated Sleeping Beauty-based oncogenic transposon plasmids into
115 rons to the presentation of song variants in sleeping birds, and by examining HVC activity in singing
118 However, recent research has shown that the sleeping brain is not completely disconnected from its e
121 a flexible and task-dependent manner by the sleeping brain, all the way up to the preparation of rel
122 hatic function is primarily a feature of the sleeping brain, rather than the waking brain, and is slo
130 aging in close-to-perfect conditions, these sleeping champagne bottles awoke to tell us a chapter of
132 in the primary auditory cortex of naturally sleeping common marmosets, we show that slow-wave sleep
136 rther control for health status or nighttime sleeping duration attenuated the association for establi
137 n that daytime sleepiness, but not nighttime sleeping duration, is one of the early nonmotor symptoms
138 thors examined daytime napping and nighttime sleeping durations, reported in 1996-1997 by 220,934 US
145 rt system administered questions on life and sleeping habits; health; and sleep, mental, and organic
146 esting (P = 0.001), stressed (P = 0.037) and sleeping heart rate (P = 0.038) were increased compared
147 rt devices were fitted for 7 days to measure sleeping heart rate, activity levels, and resting, activ
148 eviant external stimuli detected by the less-sleeping hemisphere caused more arousals and faster beha
149 me in bed during weekdays, and later weekend sleeping hours correlate with smaller brain grey matter
157 in one hundred sixty-two 2- to 25-month-old sleeping infants (60 epsilon4 carriers and 102 noncarrie
159 uction of solid foods), and early childhood (sleeping <12 h/d, presence of a television set in the
160 egulation and control found in bihemispheric sleeping mammals and the harbor porpoise were present in
161 egulation and control found in bihemispheric sleeping mammals were present in the harbor porpoise, wi
164 roup reported less interference from pain in sleeping (mean difference -0.9 points, 95% CI -1.63 to -
165 rapid eye movement sleep (P < 0.001) and the sleeping metabolic rate (P = 0.02), increased glucose (P
166 nergy expenditure expressed as a multiple of sleeping metabolic rate (PALSMR) and resting metabolic r
167 stage for the whole night and separately for sleeping metabolic rate (SMR; ie, 3-h period during the
169 cooling of lightly anesthetized or naturally sleeping mice disrupts thalamocortical slow oscillation
170 k for crash compared with those who reported sleeping more than 6 hours (relative risk [RR], 1.21; 95
173 as protein levels are up-regulated in short-sleeping mutants and also in wild type animals following
174 emically mutagenized flies to identify short-sleeping mutants and found one, redeye (rye) that shows
178 or only 0.69 h d(-1) (7.4% of the time spent sleeping on land), indicating that ecological demands fo
179 l venous pressure or ocular compression from sleeping on the surgical side, followed by sudden decomp
180 ation sessions did not prevent patients from sleeping; on the contrary, they seem to aid sleep when c
181 ce an exogenous stressor, such as prone/side sleeping or soft bedding, during a critical developmenta
185 and ambient temperature on human resting or sleeping patterns using mobile phone data of a large num
187 by sleep deprivation or caffeine during the sleeping period potentiates light resetting of the maste
191 , a kinase partner of CycA, rescue the short-sleeping phenotype of tara and CycA mutants, while incre
193 idem (Ambien) is the most widely prescribed "sleeping pill." It makes the inhibitory neurotransmitter
196 es, addition of hydrocortisone reduced total sleeping problems and disorders of initiating and mainta
198 e SCORAD), symptoms (POEM, VAS pruritus, VAS sleeping problems) and previous treatment of AD were ass
203 Trypanosoma brucei, the causative agent of sleeping sickness (Human African Trypanosomiasis, HAT),
204 orcement of surveillance, for the control of sleeping sickness (human African trypanosomiasis, HAT).
205 e Trypanosoma brucei, the causative agent of sleeping sickness across sub-Saharan Africa, depends on
207 oma brucei is the causative agent of African sleeping sickness and is known for its unique RNA proces
209 cei, the causative pathogen of human African sleeping sickness and nagana in domestic animals, myo-in
210 trends in the development of diagnostics for sleeping sickness are considered and progress towards a
211 soma brucei rhodesiense causes human African sleeping sickness because it has evolved an inhibitor of
214 cei causes African trypanosomiasis, known as sleeping sickness in humans and nagana in domestic anima
215 the diseases caused by African trypanosomes: sleeping sickness in humans and Nagana in livestock.
226 ction of rare cell types in blood (including sleeping sickness parasites), and has the potential to e
229 rucei causes human African trypanosomiasis ("sleeping sickness") across sub-Saharan Africa and is a m
230 ambiense Human African Trypanosomiasis (HAT, sleeping sickness), a disease that has often been consid
231 en argued that the risk for trypanosomiasis (sleeping sickness), carried by tsetse flies in bushy env
232 copeia for human African trypanosomiasis (or sleeping sickness), orally dosed fexinidazole stands poi
233 tive agent of Human African Trypanosomiasis (sleeping sickness), yet little is known about which PKs
235 oma brucei is the causative agent of African sleeping sickness, a devastating disease endemic to sub-
237 ing target to develop new treatments against sleeping sickness, a fatal disease caused by this protoz
238 t and Southern Africa are foci for Rhodesian sleeping sickness, a fatal zoonotic disease caused by tr
239 animal trypanosomiases, including Rhodesian sleeping sickness, a zoonosis associated with wilderness
241 ovide different levels of protection against sleeping sickness, but this comes with an increased risk
243 anosoma brucei, a causative agent of African Sleeping Sickness, constantly changes its dense variant
244 osoma brucei, the etiologic agent of African Sleeping Sickness, deploys an RNA pol II that contains a
245 osoma brucei, the causative agent of African sleeping sickness, differs from its human host in severa
246 anosoma brucei, the causative agent of human sleeping sickness, has an intrinsic circadian clock that
247 Human African trypanosomiasis (HAT), or sleeping sickness, is a major threat to human health thr
249 osoma brucei, the causative agent of African sleeping sickness, is transmitted to its mammalian host
250 Trypanosoma brucei, the etiological agent of sleeping sickness, localized its replication origins to
251 he parasitic trypanosomes that cause African sleeping sickness, mating occurs during transmission by
252 oma brucei is the causative agent of African sleeping sickness, putting at risk up to 50 million peop
253 tance against Trypanosoma that cause African sleeping sickness, resulting in positive selection of th
254 ite Trypanosoma brucei, which causes African sleeping sickness, TbISWI down-regulates RNA polymerase
255 s typified by the causative agent of African sleeping sickness, Trypanosoma brucei In mitochondria of
256 energy metabolism in the causative agent of sleeping sickness, Trypanosoma brucei, with that of huma
257 can trypanosomes, parasites that cause human sleeping sickness, undergo a density-dependent different
276 osoma brucei, the causative agent of African sleeping sickness; and Plasmodium spp., the causative ag
277 ge attraction and repulsion from the troop's sleeping site, to relatively local influences including
278 k factors for infants include prone and side sleeping, soft bedding, bed sharing, inappropriate sleep
280 ing with her infant on the same bed or other sleeping surfaces for nighttime sleep or during the majo
281 cond (recovery) night of sleep revealed that sleeping the first half of the night, which is dominated
284 glycemia associated with different levels of sleeping time (<11.0, 11.0-11.9, and >/=12.0 hours/day)
285 (SWS), rapid eye movement (REM)-sleep, total sleeping time (TST), sleep stage 2 (S2), and QS [(SWS +
286 based on arbitrary threshold parameters for sleeping time and number of citations, applied to small
287 rse association of either indoor activity or sleeping time with the risk of hyperglycemia among offsp
288 tion of physical activity, TV watching time, sleeping time with the risks of obesity and hyperglycemi
290 e spontaneous cortical activity of naturally sleeping toddlers with autism, but not in toddlers with
291 of 1371; 1.10, 1.04-1.16; p=0.001), and baby sleeping under bednet for 8-56 days (4548 [79%] of 5756
292 ill at high altitude and whether training or sleeping under normobaric hypoxic conditions in the week
295 cellular recording and labeling in naturally sleeping-waking, head-fixed rats, we investigated the di
298 r orthokeratology (OR, undefined; P = 0.02), sleeping while wearing lenses (OR, 8.00; P = 0.04), stor
299 haring, defined as the mother lying down and sleeping with her infant on the same bed or other sleepi
300 nmental awareness and aerodynamic control by sleeping with only one eye closed and one cerebral hemis
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。